These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35102361)

  • 1. Equitable access to COVID-19 vaccines makes a life-saving difference to all countries.
    Ye Y; Zhang Q; Wei X; Cao Z; Yuan HY; Zeng DD
    Nat Hum Behav; 2022 Feb; 6(2):207-216. PubMed ID: 35102361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccine inequity in African low-income countries.
    Kunyenje CA; Chirwa GC; Mboma SM; Ng'ambi W; Mnjowe E; Nkhoma D; Ngwira LG; Chawani MS; Chilima B; Mitambo C; Crampin A; Mfutso-Bengo J
    Front Public Health; 2023; 11():1087662. PubMed ID: 36950103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.
    Yin S; Ren J; Xue J; Li P; Luo J; Yin J; Luo L; Li Z; Luo G
    Int J Infect Dis; 2023 Jul; 132():9-16. PubMed ID: 37068582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.
    Glazik R; Moore H; Kennedy D; Bower H; Rohan H; Sharp A; Seale AC
    PLoS One; 2021; 16(11):e0260041. PubMed ID: 34818367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Global Survey of COVID-19 Vaccine Acceptance Among Healthcare Workers.
    Noushad M; Rastam S; Nassani MZ; Al-Saqqaf IS; Hussain M; Yaroko AA; Arshad M; Kirfi AM; Koppolu P; Niazi FH; Elkandow A; Darwish M; Abdalla Nassar AS; Abuzied Mohammed SO; Abdalrady Hassan NH; Abusalim GS; Samran A; Alsalhani AB; Demachkia AM; de Melo RM; Luddin N; Husein A; Habib A; Suleyman F; Osman HA; Al-Awar MS; Dimashkieh MR; Swapna LA; Barakat A; Alqerban A
    Front Public Health; 2021; 9():794673. PubMed ID: 35211453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
    Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
    Borges LC; Zeferino de Menezes H; Crosbie E
    Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
    Duroseau B; Kipshidze N; Limaye RJ
    Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan.
    Adejumo OA; Adejumo OA
    Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
    Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
    S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap".
    Ortiz-Millán G
    Int J Health Policy Manag; 2024; 13():8516. PubMed ID: 39099496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lockdowns and low- and middle-income countries: building a feasible, effective, and ethical COVID-19 response strategy.
    Eyawo O; Viens AM; Ugoji UC
    Global Health; 2021 Jan; 17(1):13. PubMed ID: 33472638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.
    Polašek O; Wazny K; Adeloye D; Song P; Chan KY; Bojude DA; Ali S; Bastien S; Becerra-Posada F; Borrescio-Higa F; Cheema S; Cipta DA; Cvjetković S; Castro LD; Ebenso B; Femi-Ajao O; Ganesan B; Glasnović A; He L; Heraud JM; Igwesi-Chidobe C; Iversen PO; Jadoon B; Karim AJ; Khan J; Biswas RK; Lanza G; Lee SW; Li Y; Liang LL; Lowe M; Islam MM; Marušić A; Mshelia S; Manyara AM; Htay MN; Parisi M; Peprah P; Sacks E; Akinyemi KO; Shahraki-Sanavi F; Sharov K; Rotarou ES; Stankov S; Supriyatiningsih W; Chan BT; Tremblay M; Tsimpida D; Vento S; Glasnović JV; Wang L; Wang X; Ng ZX; Zhang J; Zhang Y; Campbell H; Chopra M; Cousens S; Krstić G; Macdonald C; Mansoori P; Patel S; Sheikh A; Tomlinson M; Tsai AC; Yoshida S; Rudan I
    J Glob Health; 2022; 12():09003. PubMed ID: 35475006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.